Butalbital And Acetaminophen Tablet
Product Images NDC 81005-123

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Butalbital And Acetaminophen (NDC 81005-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aarkish Pharmaceuticals Nj Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Butalbitalacetaminophen-aarkish-cont-label (Butalbitalacetaminophen Aarkish Cont Label.jpg)

This text appears to be the labeling information for a medication. It mentions the drug's NDC code (81005-123-01), which is used for identification. The recommended adult dosage is 1 or 2 tablets every four hours, with a maximum daily dose of 6 tablets. The medication contains Butalbital and Acetaminophen. It should be stored at a temperature of 20° to 25°C (68° to 77°F). The medication should be kept out of the reach of children. The manufacturer is Aarkish Pharmaceuticals NJ Inc. located in Fairfield, NJ 07004.*

FDA Label Image

Butalbitalacetaminophen-aarish-structure1 (Butalbitalacetaminophen Aarkish Structure1.jpg)

FDA Label Image

Butalbitalacetaminophen-aarish-structure2 (Butalbitalacetaminophen Aarkish Structure2.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.